Artemis Medicare Services Ltd. (ARTEMISMED): Artemis Medicare Services Share Price hits fresh 52-week high at Rs 346.75
- September 1, 2026
- Posted by: Harsh Piplani
- Category: News
Artemis Medicare Services Share Price was at Rs 346.75, down 0.56% from the previous close, after touching a fresh 52-week high of Rs 349.30. The company’s market capitalisation stood at Rs 5,611.96 crore as ARTEMISMED remained in focus in stock news today. The latest Univest data confirms the yearly high event and shows a narrow intraday range around the peak, but it does not establish a company-specific catalyst. Artemis Medicare Services Share Price Today is therefore relevant for readers tracking price action, valuation and sector context in Indian stock market updates.
The stock opened at Rs 348 and moved between Rs 343.45 and Rs 349.30 during the latest update time of 11 September 2026 at 9:22 AM IST. Turnover stood at Rs 0.32 crore. For readers looking at Artemis Medicare Services Stock News, the main question is not why a trigger appeared, but what the confirmed data says about the move, the yearly high and the company’s valuation profile versus peers.
Artemis Medicare Services Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 346.75 |
| Previous Close | Rs 348.7 |
| Today's Move | Rs -1.95 (-0.56%) |
| Open | Rs 348 |
| High | Rs 349.3 |
| Low | Rs 343.45 |
| Turnover | Rs 0.32 crore |
| Market Capitalisation | Rs 5,611.96 crore |
Artemis Medicare Services Ltd. (ARTEMISMED) traded at Rs 346.75 versus the previous close of Rs 348.7, a fall of 0.56%. The stock opened at Rs 348, reached a high of Rs 349.3 and touched a low of Rs 343.45.
Artemis Medicare Services Share Price Today shows a move from Rs 348.70 to Rs 346.75, a decline of Rs 1.95 or 0.56% at the latest update. Even so, the stock touched Rs 349.30, which matched its fresh 52-week high, before trading slightly below that level. The day’s range ran from Rs 343.45 to Rs 349.30, while the opening print was Rs 348.00.
That means the stock was trading just 0.00% above the earlier 52-week peak because the intraday high matched the prior high exactly. On a simple event basis, Artemis Medicare Services Share Price confirms a one-year high print and then a modest pullback from the top of the range. Turnover stood at Rs 0.32 crore, which is a factual traded-value metric only. For investors following Artemis Medicare Services Share Price Live, the key point is that the stock stayed close to its yearly peak during the latest update, keeping ARTEMISMED in Stocks in News and among 52 Week High Stocks.
Artemis Medicare Services Ltd. (ARTEMISMED) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 5,611.96 crore |
| P/E Ratio | 48.57x |
| P/B Ratio | 6.15x |
| ROE | 12.72% |
| ROCE | 15.83% |
| EPS | Rs 7.18 |
| Book Value Per Share | Rs 56.68 |
| Dividend Yield | 0.13% |
Artemis Medicare Services Ltd. (ARTEMISMED) fundamental metrics show P/E 48.57x, P/B 6.15x, ROE 12.72%, ROCE 15.83%. These figures provide context only and are not a buy or sell signal.
Artemis Medicare Services Ltd. has a market capitalisation of Rs 5611.96 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 48.57x, P/B at 6.15x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.72% and ROCE of 15.83%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 7.18, book value per share of Rs 56.68, dividend yield of 0.13%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 47.7x, median ROE of 13.39%, median ROCE of 15.86%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Hospital & Healthcare Services |
| Benchmark Scope | same industry |
| Company P/E Ratio | 48.57x |
| Benchmark Median P/E | 47.7x |
| Benchmark Average P/E | 101.55x |
| Benchmark P/E Range | 7.32x to 1,541.01x |
| Company P/B Ratio | 6.15x |
| Benchmark Median P/B | 3.82x |
| Company ROE | 12.72% |
| Benchmark Median ROE | 13.39% |
| Company ROCE | 15.83% |
| Benchmark Median ROCE | 15.86% |
| Company Market Capitalisation | Rs 5,611.96 crore |
| Benchmark Median Market Cap | Rs 520.87 crore |
Artemis Medicare Services Ltd. (ARTEMISMED) is classified under sector: Healthcare and industry: Hospital & Healthcare Services.
Artemis Medicare Services Ltd. (ARTEMISMED) has a P/E ratio of 48.57x, which is above the benchmark median of 47.7x, a difference of +1.82%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Artemis Medicare Services Ltd. (ARTEMISMED) has a ROE of 12.72%, which is below the benchmark median of 13.39%, a difference of -5%. Artemis Medicare Services Ltd. (ARTEMISMED) has a ROCE of 15.83%, which is below the benchmark median of 15.86%, a difference of -0.19%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Kovai Medical Center & Hospital Ltd. | KOVAI | 6,730.09 | 26.91 | 4.97 | 20.33 | 22.89 |
| NEPHROCARE HEALTH SERV L | NEPHROPLUS | 7,372.48 | 97.8 | 6.63 | 9.22 | 16.18 |
| Thyrocare Technologies Ltd. | THYROCARE | 9,034.22 | 50.33 | 14.1 | 29.05 | 38.3 |
| Jupiter Life Line Hospitals Ltd. | JLHL | 9,307.1 | 49.02 | 5.82 | 13.39 | 15.7 |
| Yatharth Hospital & Trauma Care Services Ltd. | YATHARTH | 9,531.85 | 52.01 | 5.16 | 10.06 | 13.3 |
Artemis Medicare Services Ltd. (ARTEMISMED) has a P/E ratio of 48.57x compared with the displayed peer median of 50.33x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 12.72% compares with a peer median of 13.39% across the companies shown in the table. ROCE stood at 15.83% versus the displayed peer median of 16.18%, providing a capital-efficiency comparison. Artemis Medicare Services Ltd. (ARTEMISMED) has a market capitalisation of Rs 5,611.96 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Artemis Medicare Services
- Artemis Medicare Services Share Price touched a fresh 52-week high of Rs 349.30 during the latest update.
- Artemis Medicare Services Share Price Today was Rs 346.75, which was Rs 1.95 below the previous close of Rs 348.70.
- Market capitalisation stood at Rs 5,611.96 crore for ARTEMISMED.
- P/E ratio was 48.57 and P/B ratio was 6.15 in the latest Artemis Medicare Services Fundamental Analysis view.
- ROE was 12.72% and ROCE was 15.83%, both useful for sector and peer comparison.
About Artemis Medicare Services
Artemis Medicare Services Ltd. operates in the Healthcare sector and the Hospital & Healthcare Services industry. Artemis Medicare Services Share Price is therefore followed as part of a listed healthcare services theme, with current attention on price action, earnings metrics and peer valuation. The company’s latest financial figures include revenue and net profit updates for recent periods, which support a basic Artemis Medicare Services Company News read-through without stretching beyond verified facts.
Frequently Asked Questions
Why did Artemis Medicare Services Share Price hit a fresh 52-week high?
Ans. Artemis Medicare Services Share Price touched Rs 349.30, which matched its fresh 52-week high during the latest update. The data confirms the price event, but it does not establish a company-specific catalyst.
What is Artemis Medicare Services Share Price today?
Ans. Artemis Medicare Services Share Price was Rs 346.75 at the latest update, down 0.56% from the previous close of Rs 348.70. It remained near the intraday peak after opening at Rs 348.00.
What is the 52-week high for ARTEMISMED?
Ans. The fresh 52-week high for ARTEMISMED was Rs 349.30. The stock traded between Rs 343.45 and Rs 349.30 during the latest update, keeping the yearly high in focus for market watchers.
What is the market capitalisation of Artemis Medicare Services?
Ans. Artemis Medicare Services had a market capitalisation of Rs 5,611.96 crore. That places it well above the sector median of Rs 520.87 crore within the same-industry benchmark comparison.
What do the valuation ratios show for Artemis Medicare Services Share Price?
Ans. Artemis Medicare Services Share Price is supported by a P/E ratio of 48.57 and a P/B ratio of 6.15. Those numbers sit above the same-industry medians in the benchmark set.
How do ROE and ROCE look for Artemis Medicare Services?
Ans. ROE stood at 12.72% and ROCE at 15.83%. ROE is below the same-industry median, while ROCE is almost in line with the benchmark, helping frame the fundamental picture.
What do EPS and book value mean for ARTEMISMED?
Ans. EPS was Rs 7.18 and book value was Rs 56.68 per share. EPS reflects earnings attributable to each share, while book value shows the accounting net worth behind each share.
How does Artemis Medicare Services compare with peers?
Ans. Compared with peers such as KOVAI, THYROCARE and JLHL, Artemis Medicare Services Share Price sits with a higher P/E than some and lower market cap than several others. Peer data helps place the valuation in context.
Track Artemis Medicare Services Share Price on Univest
Use Artemis Medicare Services Ltd. (ARTEMISMED) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
On Univest, users can track Artemis Medicare Services Share Price Live, Artemis Medicare Services Share Price Today, valuation ratios, financial results, market cap, sector context and comparable listed peers. Univest also helps readers follow Artemis Medicare Services Latest News and Artemis Medicare Services Share News in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
